Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · IEX Real-Time Price · USD

1.760

-0.140 (-7.37%)

At close: Jul 2, 2024, 4:00 PM

1.750

-0.010 (-0.57%)

After-hours: Jul 2, 2024, 7:42 PM EDT

Regulus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2010
Net Income	-30.04	-28.32	-27.81	-15.73	-18.59	Upgrade
Depreciation & Amortization	0.23	0.12	0.46	0.47	0.93	Upgrade
Share-Based Compensation	2.8	2.18	2.92	2.61	2.29	Upgrade
Other Operating Activities	0.24	0.5	0.3	0.11	-4.45	Upgrade
Operating Cash Flow	-26.77	-25.53	-24.13	-12.54	-19.82	Upgrade
Capital Expenditures	-0.61	-0.36	-0.25	0	0.1	Upgrade
Change in Investments	15.1	-14.76	0	0	0	Upgrade
Other Investing Activities	-	-	-	-0.01	-0.02	Upgrade
Investing Cash Flow	14.49	-15.12	-0.25	-0.01	0.07	Upgrade
Share Issuance / Repurchase	15.12	4.49	53.82	19.13	42.17	Upgrade
Debt Issued / Paid	-3.3	0	-0.08	-9.62	-2.24	Upgrade
Financing Cash Flow	11.82	4.49	53.74	9.51	39.93	Upgrade
Net Cash Flow	-0.46	-36.16	29.36	-3.03	20.19	Upgrade
Free Cash Flow	-27.38	-25.89	-24.38	-12.54	-19.72	Upgrade
Free Cash Flow Margin	-	-	-	-125.28%	-288.70%	Upgrade
Free Cash Flow Per Share	-1.44	-1.70	-2.85	-3.58	-11.43	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).